Inhibikase Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 13,276 | 0.215% |
Institutions | 486,418 | 7.86% |
Individual Insiders | 889,887 | 14.4% |
General Public | 4,796,699 | 77.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
889,229 | US$2.0m | 0% | no data | |||
223,500 | US$498.4k | 0% | 100.0% | |||
82,045 | US$183.0k | -6.18% | no data | |||
60,268 | US$134.4k | 1.5% | no data | |||
28,692 | US$64.0k | 0% | no data | |||
28,333 | US$63.2k | 0% | 0.24% | |||
24,422 | US$54.5k | 51.5% | no data | |||
19,644 | US$43.8k | -6.35% | 0.01% | |||
10,084 | US$22.5k | 0% | no data | |||
7,357 | US$16.4k | 0% | no data | |||
5,919 | US$13.2k | 169% | no data | |||
5,500 | US$12.3k | 0% | 0.08% | |||
2,000 | US$4.5k | 0% | no data | |||
1,667 | US$3.7k | 0% | no data | |||
658 | US$1.5k | 0% | no data | |||
167 | US$372.5 | -16.5% | no data | |||
62 | US$138.0 | 0% | no data | |||
34 | US$75.9 | 6.25% | no data |